Page 17 - Clinical Program News Today

The Biden administrations emphasis on race and gender ideology undercuts the military's mission to defend the homeland, a GOP report alleged.

09.11.2022 - TRV045 demonstrated a favorable tolerability profile with no reported SAEs and no lymphopenia Nonclinical study showed anti-inflammatory signaling, suggesting a potential disease-modifying effect of TRV045 in the treatment of epilepsy, based on ... Seite 1

Third-Quarter 2022 Results: -- Net Sales of $925.4 Million -- -- GAAP Net Income of $135.8 Million; Adjusted EBITDA of $335.3 Million, Which Includes $19.0 Million of Acquired IPR&D and Milestones

27.10.2022 - - Ended the quarter with $42.7 million in cash and investments- Burn rate of $4.5 million for the quarter- Runway extends through the end of 2024 including release of SAVVE topline pivotal trial data and initiation of TAVVE first in human ... Seite 1

Alzheimer’s Patients Who Complete Participation in a Phase 3 Study of Simufilam are Eligible to Enroll52-week Study of Simufilam 100 mgUp to 1,600 Patients...

First presentation of RSV Older Adult vaccine candidates pivotal phase III efficacy and safety data New data showing Shingrix... | October 12, 2022

Professor Colene Robinson, co-director of Colorado Law’s Clinical Program, and Josi McCauley ’06 each received awards at the 2022 Colorado Office of the Child’s Representative (OCR) Annual Conference, held on September 12 and 13.

Download logoOver 792 million people in Africa live with a Mental Health (MH) conditions. Like many African countries, Zimbabwe has inadequate MH

/PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective...

/PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective...